regulatory
confidence high
sentiment negative
materiality 0.85
VERU INC. (VERU): Nasdaq/NYSE listing notice — Veru receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period through July 23, 2024
VERU INC.
- Nasdaq notified Veru on Jan 25, 2024 that its closing bid price was below $1.00 for 30 consecutive business days.
- Company has until July 23, 2024 to regain compliance by closing at $1.00 or more for 10 consecutive trading days.
- Failure to cure may qualify for an additional 180-day period if other listing standards are met and a reverse stock split is considered.
- No immediate impact on trading; stock continues on Nasdaq Capital Market during the cure period.